Friday 6 November 2026
Export ISRG’s income statement to Excel — free account
Intuitive Surgical, Inc.
ISRG Healthcare Medical Instruments & Supplies
Intuitive Surgical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $10.1 billion, up 20.5% from fiscal 2024.
- Revenue
- +21.7%
- EPS
- −24.2%
- Free cash flow
- +51.0%
Quarter to September 2026, against a year earlier
465.68
16.42
−3.41%
Follow ISRG
Alert me
Intuitive Surgical, Inc. (ISRG) Total debt
Intuitive Surgical, Inc.'s total debt at the end of fiscal 2022 was $94.0M, up 8.05% from $87.0M in fiscal 2021. Intuitive Surgical, Inc. ranks 23rd of 50 Medical Instruments & Supplies companies by total debt.
Total debt, annual
Embed this chart
Annual newest first
| Period | Total debt | Change |
|---|---|---|
| FY2022 | $94.0M | 8.05% |
| FY2021 | $87.0M | 8.75% |
| FY2020 | $80.0M | 3.90% |
| FY2019 | $77.0M | — |
Quarterly newest first
| Period | Total debt | Change |
|---|---|---|
| Dec 2022 | $94.0M | 8.05% |
| Dec 2021 | $87.0M | 8.75% |
| Dec 2020 | $80.0M | 3.90% |
| Dec 2019 | $77.0M | — |
Total debt against peers
| Company | Total debt |
|---|---|
| BDX Becton, Dickinson and Company compare | $13.5B |
| MDLN Medline Inc. compare | $12.6B |
| BAX Baxter International Inc. compare | $8.6B |
| ALC Alcon compare | $4.7B |
| COO The Cooper Companies, Inc. compare | $2.5B |
| SOLV Solventum Corporation compare | $507.0M |
| RMD ResMed Inc. compare | $249.6M |
| WST West Pharmaceutical Services, Inc. compare | $202.9M |
| ISRG Intuitive Surgical, Inc. | $94.0M |
What Total debt is
Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.
Long Term Debt (Total) + Current Part of Debt
More on ISRG
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement